Download PDF
Thromb Haemost 1985; 54(03): 639-644
DOI: 10.1055/s-0038-1660088
Original Article
Schattauer GmbH Stuttgart

Plasma Fibronectin Enhances Fibrinolytic System In Vitro

Nisan Gilboa
The Wadsworth Center for Laboratories and Research, New York State Department of Health, and the Departments of Pediatrics and Physiology, Albany Medical College, Albany, New York, USA
,
John E Kaplan
The Wadsworth Center for Laboratories and Research, New York State Department of Health, and the Departments of Pediatrics and Physiology, Albany Medical College, Albany, New York, USA
› Author Affiliations
Further Information

Publication History

Received 12 February 1985

Accepted 30 July 1985

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The effects of plasma fibronectin on the fibrinolytic system were studied in vitro. Fibronectin caused a time and concentration-dependent increase (up to 99% with 330 ug/ml) in the amidolytic activity of tissue plasminogen activator (TPA) but not of urokinase. In the presence of fibronectin the Km of the amidolytic activity of TPA decreased without a change in Vmax. It also caused a concentration-dependent increase in lys-plas-minogen activation by TPA (up to 825% with 375 ug/ml) and by urokinase (up to 400% with 250 ug/ml), as well as in the amidolytic activity of plasmin (up to 55% with 300 ug/ml). Fibronectin did not enhance the activation of glu-plasminogen. In the presence of fibronectin the Km of lys-plasminogen activation decreased without a change in Vmax. In purified systems fibronectin significantly shortened the clot lysis time (CLT) by up to 28% and 30% in TPA- and plasmin-activated lysis, respectively. The presence of Ca2+ did not change fibronectin’s effect on CLT. Clots of non-fibronectin-depleted plasma were lysed up to about twice as fast as the clots of fibronectin-depleted plasma. In conclusion, physiologic concentrations of fibronectin enhanced the fibrinolytic system in vitro. Further studies will be required to elucidate the mechanisms involved and to document whether fibronectin has a similar effect in vivo.

Keywords

Fibronectin - Tissue plasminogen activator - Urokinase - Plasmin - Plasminogen - Fibrinolysis
 

  • References

  • 1 Mosher DF. Fibronectin-relevance to hemostasis and thrombosis. In Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) J. B. Lippincott; Philadelphia: 1981: 174-184
  • 2 Kaplan JE, Snedeker DW. Maintenance of fibrin solubility by plasma fibronectin. J Lab Clin Med 1980; 96: 1054-1061
    PubMedGoogle Scholar
  • 3 Iwanaga S, Nakamura S, Suzuki K. Bovine plasma factor XIII: Its molecular structure and functions. Excerpta Med Int Cong Sci 1976; 415: 393-398
    PubMedGoogle Scholar
  • 4 Mosher DF. Cross-linking of cold-insoluble globulin by fibrin stabilizing factor. J Biol Chem 1975; 250: 6614-6621
    PubMedGoogle Scholar
  • 5 Mosher DF, Schad PE, Kleinman HK. Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa. J Clin Invest 1979; 64: 781-787
    CrossrefPubMedGoogle Scholar
  • 6 Chen AB, Amrani DL, Mossesson MW. Heterogeneity of the cold- insoluble globulin of human plasma (CIG), a circulating cell surface protein. Biochim Biophys Acta 1977; 493: 310-322
    CrossrefPubMedGoogle Scholar
  • 7 Jilek F, Hormann H. Cold-insoluble globulin. III Cyanogen bromide and plasminolysis fragments containing a label introduced by trans-amidation. Hoppe Seylers Z Physiol Chem 1977; 358: 1165-1168
    PubMedGoogle Scholar
  • 8 Mosher DF, Proctor RA. Binding and factor XIII a-mediated crosslinking of a 27kd fragment of fibronectin to Staphylococcus aureus. Science 1980; 209: 927-929
    CrossrefPubMedGoogle Scholar
  • 9 Hormann H, Seidl M. Affinity chromatography on immobilized fibrinogen and fibrin monomer. III. The fibrin affinity center of fibronectin. Hoppe Seylers Z Physiol Chem 1980; 361: 1449-1452
    PubMedGoogle Scholar
  • 10 Iwanaga S, Suzuki K, Hashimoto S. Bovine plasma cold-insoluble globulin: Gross structure and function. Ann NY Acad Sci 1978; 312: 56-73
    CrossrefPubMedGoogle Scholar
  • 11 Blumenstock FA, Saba TM, Weber P. An affinity method for rapid purification of opsonic alpha-2-SB glycoprotein from serum. Adv Shock Res 1979; 2: 55
    PubMedGoogle Scholar
  • 12 Blumenstock FA, Weber P, Saba TM, Laffin R. Electroimmunoassay of alpha-2-globulin opsonic protein during reticuloendothelial blockade. Am J Physiol 1977; 232: R80-R87
    PubMedGoogle Scholar
  • 13 Deutch D, Mertz E. Plasminogen purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
    CrossrefPubMedGoogle Scholar
  • 14 Markus G, Depasquale JL, Wissler FC. Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. J Biol Chem 1978; 253: 727-732
    PubMedGoogle Scholar
  • 15 Robbins KC, Summaria L. Plasminogen and Plasmin. In Proteolytic Enzymes Lorand L. (ed.) Academic Press; NY: Methods in Enzymology 1976. XLV 257
  • 16 Chase Jr T, Shaw E. Comparison of the esterase activities of trypsin, plasmin, and thrombin, on quanedinobenzoate esters. Titration of the enzymes. Biochemistry 1969; 8: 2212-2224
    PubMedGoogle Scholar
  • 17 Claeys H, Molla A, Verstraete M. Conversion of NH2-terminal glutamic acid to NH2-terminal lysine human plasminogen by plasmin. Thromb Res 1973; 3: 515
    CrossrefPubMedGoogle Scholar
  • 18 Marquardt DW. An algorhythm for least squares estimation of non linear parameters. J Soc Ind Appl Math 1963; 11: 431-441
    CrossrefPubMedGoogle Scholar
  • 19 Gilboa N, Erdman J, Urizar RE. Quantative spectrophotometric assay of renal tissue plasminogen activator. Kidney Int 1982; 22: 80-83
    CrossrefPubMedGoogle Scholar
  • 20 Leytus SP, Peltz GA, Lin H-Y, Cannon TF, Peltz SW, Livingstone DC, Brocklehurst JR, Mangel WF. A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase. Biochemistry 1981; 20: 4307-4314
    CrossrefPubMedGoogle Scholar
  • 21 Ranby M, Norrman B, Wallen P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27: 743-749
    CrossrefPubMedGoogle Scholar
  • 22 Verheijen JH, Nieuwenhuizen W, Wijngaards G. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments. Thromb Res 1982; 27: 377-385
    CrossrefPubMedGoogle Scholar
  • 23 Allen RA. An enhancing effect of poly-lysine on the activation of plasminogen. Thromb Haemostas 1982; 47: 41-45
    PubMedGoogle Scholar
  • 24 Nieuwenhuizen W, Verheijen JH, Vermond A, Chang GT G. Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2. Biochim Biophys Acta 1983; 755: 531-533
    CrossrefPubMedGoogle Scholar
  • 25 Lijnen HR, Van Hoef B, Collen D. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase. Eur J Biochem 1984; 144: 541-544
    CrossrefPubMedGoogle Scholar
  • 26 Radcliffe R, Heinze T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: A possible additional role for plasminogen activator?. Arch Biochem Biophys 1981; 211: 750-761
    CrossrefPubMedGoogle Scholar
  • 27 Radcliffe R. A critical role of lysine residues in the stimulation of tissue plasminogen activator by denatured proteins and fibrin clots. Biochim Biophys Acta 1983; 743: 422-430
    CrossrefPubMedGoogle Scholar
  • 28 Ranby M, Bergsdorf N, Norrman B, Suenson E, Wallen P. Tissue plasminogen activitor kinetics. In Progress in Fibrinolysis Davidson JF, Bachmann F, Bouvier CA, Kruithof E KD. (eds). Vol. VI Churchill Livingston; Edinburgh: 1983: 182-184
  • 29 Wijngaards G. Determination of plasminogen activator inhibiting activity of an extract from human placenta. In Progress in Chemical Fibrinolysis and Thrombolysis Davidson JT, Cepelak V, Samama MM, Desnoyers PC. (eds). Vol IV Raven Press; New York: 1979: 149
  • 30 Carlin G, Bang NU. Enhancement of plasminogen activation and hydrolysis of purified fibrinogen and fibrin by dextran 70. Thromb Res 1980; 19: 535-546
    CrossrefPubMedGoogle Scholar
  • 31 Takada Y, Takada A. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase. Thromb Res 1979; 16: 865-869
    CrossrefPubMedGoogle Scholar
  • 32 Dahl R, Venge P. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes. Thromb Res 1979; 14: 599-608
    CrossrefPubMedGoogle Scholar
  • 33 Banyai L, Varaddi A, Patthy L. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS 1983; 163: 37-41
    CrossrefPubMedGoogle Scholar
  • 34 Niewiarowska J, Cierniewski CS. Inhibitory effect of fibronectin on the fibrin formation. Thromb Res 1982; 27: 611-618
    CrossrefPubMedGoogle Scholar
  • 35 Kamykowski GW, Mosher DF, Lorand L, Ferry JD. Modification of shear modulus and creep compliance of fibrin clots by fibronectin. Biophys Chem 1981; 13: 25-28
    CrossrefPubMedGoogle Scholar
  • 36 Chow TW, Mclntire LV, Peterson DM. Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. Thromb Res 1983; 29: 243-248
    CrossrefPubMedGoogle Scholar
  • 37 Niewiarowska J, Cierniewski CS. Quantitation of the fibronectin interaction with fibrin monomers. Thromb Haemostas 1983; 50: 28 (Abstr)
    PubMedGoogle Scholar
  • 38 Marder VJ, Francis CW, Doolittle RF. Fibrinogen structure and physiology. In Hemostasis and Thrombosis Colman RW. et al. (eds) 1982. pp 145-163